These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34476755)

  • 1. Mast Cell Stabilizers in the Treatment of Rosacea: A Review of Existing and Emerging Therapies.
    Marchitto MC; Chien AL
    Dermatol Ther (Heidelb); 2021 Oct; 11(5):1541-1549. PubMed ID: 34476755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosacea: an update.
    Buechner SA
    Dermatology; 2005; 210(2):100-8. PubMed ID: 15724091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rosacea: pathogenesis, clinical forms and therapy].
    Preisz K; Kárpáti S
    Orv Hetil; 2010 Jul; 151(30):1209-14. PubMed ID: 20650811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential role of microorganisms in the development of rosacea.
    Lazaridou E; Giannopoulou C; Fotiadou C; Vakirlis E; Trigoni A; Ioannides D
    J Dtsch Dermatol Ges; 2011 Jan; 9(1):21-5. PubMed ID: 21059171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papulopustular rosacea, skin immunity and Demodex: pityriasis folliculorum as a missing link.
    Forton FM
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):19-28. PubMed ID: 22017468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Medical Therapies in Rosacea: A Narrative Review.
    Choe J; Barbieri JS
    Dermatol Ther (Heidelb); 2023 Dec; 13(12):2933-2949. PubMed ID: 37824060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosacea: I. Etiology, pathogenesis, and subtype classification.
    Crawford GH; Pelle MT; James WD
    J Am Acad Dermatol; 2004 Sep; 51(3):327-41; quiz 342-4. PubMed ID: 15337973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivermectin 1% (CD5024) for the treatment of rosacea.
    Sahni DR; Feldman SR; Taylor SL
    Expert Opin Pharmacother; 2018 Apr; 19(5):511-516. PubMed ID: 29544355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical application of 1-methylnicotinamide in the treatment of rosacea: a pilot study.
    Wozniacka A; Wieczorkowska M; Gebicki J; Sysa-Jedrzejowska A
    Clin Exp Dermatol; 2005 Nov; 30(6):632-5. PubMed ID: 16197374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical metronidazole maintains remissions of rosacea.
    Dahl MV; Katz HI; Krueger GG; Millikan LE; Odom RB; Parker F; Wolf JE; Aly R; Bayles C; Reusser B; Weidner M; Coleman E; Patrignelli R; Tuley MR; Baker MO; Herndon JH; Czernielewski JM
    Arch Dermatol; 1998 Jun; 134(6):679-83. PubMed ID: 9645635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors.
    Two AM; Wu W; Gallo RL; Hata TR
    J Am Acad Dermatol; 2015 May; 72(5):749-58; quiz 759-60. PubMed ID: 25890455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the pathogenesis of rosacea: how angiogenesis and mast cells may participate in a complex multifactorial process.
    Aroni K; Tsagroni E; Kavantzas N; Patsouris E; Ioannidis E
    Arch Dermatol Res; 2008 Mar; 300(3):125-31. PubMed ID: 18071725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of permethrin 2.5% with tea tree oil gel on rosacea treatment: A double-blind, controlled clinical trial.
    Ebneyamin E; Mansouri P; Rajabi M; Qomi M; Asgharian R; Azizian Z
    J Cosmet Dermatol; 2020 Jun; 19(6):1426-1431. PubMed ID: 31613050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the diagnosis and treatment of rosacea.
    Scheinfeld N; Berk T
    Postgrad Med; 2010 Jan; 122(1):139-43. PubMed ID: 20107297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics.
    Holmes AD; Steinhoff M
    Exp Dermatol; 2017 Aug; 26(8):659-667. PubMed ID: 27376863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatology: how to manage rosacea in skin of colour.
    Maliyar K; Abdulla SJ
    Drugs Context; 2022; 11():. PubMed ID: 35720055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosacea: a review of current topical, systemic and light-based therapies.
    Kennedy Carney C; Cantrell W; Elewski BE
    G Ital Dermatol Venereol; 2009 Dec; 144(6):673-88. PubMed ID: 19907406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new superficial needle-scraping method for assessing Demodex density in papulopustular rosacea.
    Huang HP; Hsu CK; Lee JY
    J Cosmet Dermatol; 2020 Apr; 19(4):896-900. PubMed ID: 31343825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permethrin 5% cream versus metronidazole 0.75% gel for the treatment of papulopustular rosacea. A randomized double-blind placebo-controlled study.
    Koçak M; Yağli S; Vahapoğlu G; Ekşioğlu M
    Dermatology; 2002; 205(3):265-70. PubMed ID: 12399675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional evidence that rosacea pathogenesis may involve demodex: new information from the topical efficacy of ivermectin and praziquantel.
    Abokwidir M; Fleischer AB
    Dermatol Online J; 2015 Sep; 21(9):. PubMed ID: 26437294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.